Company attributes
Industry
Location
B2X
CEO
Founder
Number of Employees (Ranges)
1 – 10
Email Address
info@eclipsebio.com0
Phone Number
+18557272547
Full Address
6195 Cornerstone Ct E Ste 105 San Diego, CA, 92121-4728 United States
5770 Oberlin Dr. San Diego, 92121 CA0
DUNS Number
080775928
Founded Date
January 1, 2017
Total Funding Amount (USD)
28,950,020
Latest Funding Round Date
March 22, 2022
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
14,000,000
Eclipse Bioinnovations is an American company founded by Peter Chu in 2017. It conducts research on RNA Next Generation sequencing. Its product, eCLIP, analyses protein gene partners and maps to customize RNA medicines for patients.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
